197 related articles for article (PubMed ID: 6156326)
1. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
Turley SD; Dietschy JM
J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
[TBL] [Abstract][Full Text] [Related]
2. Effects of plasma cholesterol lowering agents on hepatobiliary lipid metabolism and cholesterol turnover in the rhesus monkey.
Redinger RN; Passi RB
Can J Physiol Pharmacol; 1979 Mar; 57(3):235-41. PubMed ID: 109175
[TBL] [Abstract][Full Text] [Related]
3. Regulation of biliary cholesterol output in the rat: dissociation from the rate of hepatic cholesterol synthesis, the size of the hepatic cholesteryl ester pool, and the hepatic uptake of chylomicron cholesterol.
Turley SD; Dietschy JM
J Lipid Res; 1979 Nov; 20(8):923-34. PubMed ID: 533827
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
Staels B; Van Tol A; Fruchart JC; Auwerx J
Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
[TBL] [Abstract][Full Text] [Related]
5. Effect of cholestyramine treatment on biliary lipid secretion rates in normolipidaemic men.
Carrella M; Ericsson S; Del Piano C; Angelin B; Einarsson K
J Intern Med; 1991 Mar; 229(3):241-6. PubMed ID: 2007842
[TBL] [Abstract][Full Text] [Related]
6. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat.
Kamisako T; Ogawa H; Yamamoto K
J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222
[TBL] [Abstract][Full Text] [Related]
7. Biliary lipid composition during treatment with different hypolipidaemic drugs.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
[TBL] [Abstract][Full Text] [Related]
8. The effects of probucol and clofibrate alone and in combination on hepatic cholesterol metabolism in the male rat.
Shand JH; West DW
Biochim Biophys Acta; 1995 Mar; 1255(2):123-30. PubMed ID: 7696326
[TBL] [Abstract][Full Text] [Related]
9. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
Maxwell RE; Nawrocki JW; Uhlendorf PD
Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the stimulatory effect of pregnenolone-16 alpha-carbonitrile on biliary cholesterol output in the rat by manipulation of the rate of hepatic cholesterol synthesis.
Turley SD; Dietschy JM
Gastroenterology; 1984 Aug; 87(2):284-92. PubMed ID: 6735074
[TBL] [Abstract][Full Text] [Related]
12. Probucol reduces hepatic cholesterol secretion in hyperlipidemic Yoshida rats.
Bravo E; Ortu G; Rivabene R; Santini MT; Cantafora A
Atherosclerosis; 1996 Jan; 119(2):223-33. PubMed ID: 8808499
[TBL] [Abstract][Full Text] [Related]
13. Altered effect of 3% dietary cholestyramine on plasma lipids and biliary bile acid output in the pregnant rat.
Innis SM
Am J Obstet Gynecol; 1984 Nov; 150(6):742-4. PubMed ID: 6496596
[TBL] [Abstract][Full Text] [Related]
14. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
Jolley CD; Dietschy JM; Turley SD
Hepatology; 2000 Dec; 32(6):1309-16. PubMed ID: 11093738
[TBL] [Abstract][Full Text] [Related]
15. Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine.
Kim DN; Lee KT; Reiner JM; Thomas WA
J Lipid Res; 1974 Jul; 15(4):326-31. PubMed ID: 4854142
[TBL] [Abstract][Full Text] [Related]
16. Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Hajri T; Chanussot F; Férézou J; Riottot M; Lafont H; Laruelle C; Lutton C
Eur J Pharmacol; 1997 Feb; 320(1):65-71. PubMed ID: 9049604
[TBL] [Abstract][Full Text] [Related]
17. Rates of sterol synthesis in the liver and extrahepatic tissues of the SHR/N-corpulent rat, an animal with hyperlipidemia and insulin-independent diabetes.
Turley SD; Hansen CT
J Lipid Res; 1986 May; 27(5):486-96. PubMed ID: 3525721
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of adipocyte cholesterol during hypolipidemic drug treatment in cholesterol-fed rats.
Krause BR; Hartman AD
Biochim Biophys Acta; 1982 Dec; 713(3):485-93. PubMed ID: 7150624
[TBL] [Abstract][Full Text] [Related]
19. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
[TBL] [Abstract][Full Text] [Related]
20. In vitro cholesterol synthesis in freshly isolated mononuclear cells of human blood: effect of in vivo administration of clofibrate and/or cholestyramine.
McNamara DJ; Davidson NO; Fernandez S
J Lipid Res; 1980 Jan; 21(1):65-71. PubMed ID: 7354255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
